Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1,715.00
+60.00
+(3.63%)
At close: February 21 at 3:29:31 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
391,867
91,434
83,029
36,772
66,616
Cost of Revenue
161,398
160,856
64,095
--
--
Gross Profit
230,469
-69,422
18,934
36,772
66,616
Operating Expense
251,448
285,438
365,376
272,228
204,153
Operating Income
-20,979
-354,860
-346,442
-235,456
-137,537
Net Non Operating Interest Income Expense
-227,162
-130,001
-90,526
-114,538
-100,513
Other Income Expense
-233,780
-166,188
-114,679
200,796
-53,720
Pretax Income
-481,921
-651,049
-551,647
-149,198
-291,770
Tax Provision
-40,467
-99,318
-38,067
-47,694
-121,726
Net Income Common Stockholders
-441,454
-551,731
-513,580
-101,504
-170,044
Diluted NI Available to Com Stockholders
-441,454
-551,731
-513,580
-101,504
-170,044
Basic EPS
-1.85
-2.43
-2.60
-0.92
-1.54
Diluted EPS
-1.85
-2.43
-2.60
-0.92
-1.54
Basic Average Shares
253,000.03
227,256.47
197,530.77
110,673.31
110,673.31
Diluted Average Shares
301,481.60
227,256.47
197,530.77
243,649.51
243,649.51
Total Operating Income as Reported
-20,979
-354,860
-346,442
-235,456
-137,537
Total Expenses
412,846
446,294
429,471
272,228
204,153
Net Income from Continuing & Discontinued Operation
-441,454
-551,731
-513,580
-101,504
-170,044
Normalized Income
-230,208.37
-417,028.36
-409,225.14
-239,689.52
-131,927.05
Interest Income
37,519
4,823
912
19
215
Interest Expense
263,024
133,167
77,474
112,971
97,466
Net Interest Income
-227,162
-130,001
-90,526
-114,538
-100,513
EBIT
-218,897
-517,882
-474,173
-36,227
-194,304
EBITDA
-189,026
-493,672
-453,764
-18,031
-177,885
Reconciled Cost of Revenue
161,398
160,856
64,095
--
--
Reconciled Depreciation
29,871
24,210
20,409
18,196
16,419
Net Income from Continuing Operation Net Minority Interest
-441,454
-551,731
-513,580
-101,504
-170,044
Total Unusual Items Excluding Goodwill
-230,610
-159,035
-112,089
203,214
-52,215
Total Unusual Items
-230,610
-159,035
-112,089
203,214
-52,215
Normalized EBITDA
41,584
-334,637
-341,675
-221,245
-125,670
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-19,364.37
-24,332.36
-7,734.14
65,028.48
-14,098.05
12/31/2020 - 6/23/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVT.VI Evotec SE
8.50
-0.82%
TKUN.TA Tikun Olam-Cannbit Pharmaceuticals Ltd
38.00
-5.00%
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
-33.33%
N4P.L N4 Pharma Plc
0.5750
0.00%
BOI.PA Boiron SA
25.20
+1.00%
TEV.F Teva Pharmaceutical Industries Limited
16.10
-2.13%
RJF.MC Laboratorio Reig Jofre, S.A.
2.6900
+1.13%
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%
DICOT.ST Dicot Pharma AB
0.2655
+1.53%
BIOG-B.ST BioGaia AB (publ)
127.00
-0.31%